Nurse Practitioner, Family · New Albany, MS
NPI
1841392784
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
200 Hwy 30 W
New Albany, MS, 38652
Phone (662) 538-2535
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
479 services
Medicare patients, 2024
239
Average age 73
Drug cost, 2024
$695K
767 prescriptions
Company payments, 2025
$2,822
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kimberly W Hardin was code 99213 (office e&m - established), 233 times for 170 patients. In total Kimberly W Hardin billed 479 services in 11 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 233 | 170 | $35.48 | $8,266 |
| 99214 Office E&M - Established | Facility | 159 | 99 | $52.70 | $8,380 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 29 | 27 | $4.91 | $143 |
| 99232 Hospital E&M - Subsequent | Facility | 25 | 19 | $48.90 | $1,223 |
By year: 2022 $46K for 819 services; 2023 $29K for 632 services; 2024 $20K for 479 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kimberly W Hardin prescribed most often to Medicare patients was Letrozole, with 75 prescriptions and refills. In total Kimberly W Hardin wrote 767 Medicare prescriptions that cost $695K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 75 | 122 | 16 | $929 |
| Potassium Chloride Generic | 67 | 85 | 23 | $805 |
| Acyclovir Generic | 44 | 46 | 14 | $428 |
| Tamoxifen Citrate Generic | 32 | 40 | Under 11 | $405 |
| Allopurinol Generic | 26 | 37 | Under 11 | $272 |
| Gabapentin Generic | 25 | 25 | Under 11 | $415 |
| Warfarin Sodium Generic | 22 | 35 | Under 11 | $123 |
| Pantoprazole Sodium Generic | 22 | 24 | Under 11 | $98.49 |
| Exemestane Generic | 19 | 28 | Under 11 | $980 |
| Hydroxyurea Generic | 16 | 30 | Under 11 | $309 |
| Ondansetron Odt Ondansetron | 15 | 15 | Under 11 | $132 |
| Clonidine Hcl Generic | 15 | 25 | Under 11 | $25.8 |
| Iressa Gefitinib | 12 | 12 | Under 11 | $93K |
| Alendronate Sodium Generic | 12 | 23 | Under 11 | $14.48 |
| Meloxicam Generic | 12 | 12 | Under 11 | $12.78 |
Brand drugs: 86 claims; generic drugs: 681 claims; opioid claims: 38.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kimberly W Hardin $2,822 ($2,822 in general payments such as food, travel and fees) from 31 companies. The largest payer was Astellas Pharma US Inc with $388.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 8 | $388 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $264 |
| E.R. Squibb & Sons, L.L.C. BMY | 16 | $256 |
| Gilead Sciences, Inc. GILD | 8 | $187 |
| Pfizer Inc. PFE | 9 | $183 |
| Merck Sharp & Dohme LLC MRK | 9 | $180 |
| Celgene Corporation BMY | 5 | $136 |
| Eisai Inc. 4523.T | 7 | $126 |
| Lilly USA, LLC LLY | 5 | $107 |
| Janssen Biotech, Inc. JNJ | 4 | $94.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.